COLLPLANT BIOTECH. IS-01 (CPT) — Financial Flexibility Index
COLLPLANT BIOTECH. IS-01 (CPT) has a Financial Flexibility Index of -0.62x as of December 2025. Free cash flow of €-2.92 Million (operating CF €-2.94 Million minus capex €15.00K) represents -1% of total liabilities (€4.70 Million). Check CPT asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
COLLPLANT BIOTECH. IS-01 Financial Flexibility Index (2021–2025)
Historical Financial Flexibility Index trend for COLLPLANT BIOTECH. IS-01 across 5 annual periods. See CPT current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for COLLPLANT BIOTECH. IS-01 (2021–2025)
Year-by-year free cash flow to debt coverage for COLLPLANT BIOTECH. IS-01. For the full company profile including market capitalisation, see COLLPLANT BIOTECH. IS-01 (CPT) total market value.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.00x | €-9.39 Million | €-9.42 Million | €4.70 Million | ▲ +23.1% |
| 2024 | -2.59x | €-13.61 Million | €-14.09 Million | €5.25 Million | ▼ -730.0% |
| 2023 | -0.31x | €-1.81 Million | €-2.76 Million | €5.79 Million | ▲ +86.1% |
| 2022 | -2.26x | €-12.38 Million | €-13.70 Million | €5.49 Million | ▼ -436.7% |
| 2021 | 0.67x | €4.09 Million | €2.50 Million | €6.10 Million | — |